Global Investing Roundups: IBM, Micron, Eli Lilly

• Eli Lilly and Co. (LLY) is in advanced talks to acquire ImClone Systems Inc (IMCL) for $70 a share, topping a rival bid from Bristol-Myers Squibb Co. (BMY), the Wall Street Journal reported yesterday (Wednesday). Bristol already owns about 17% of ImClone and has submitted an unsolicited $62-a-share bid of its own for the biotech company.

• CarMax Inc. (KMX) said yesterday (Wednesday) that it will layoff more than 600 employees, or 4% of its total work force, as it struggles with harsh credit conditions and low sales, The Associated Press reported. CarMax shares fell 64 cents, or 4.6%, to close at $13.36.

• Shares of IBM Corp. (IBM) tumbled 6% yesterday (Wednesday), their biggest drop in three years, on speculation that the company failed to meet third-quarter expectations. “There’s unconfirmed speculation that they are going to bring down their numbers for the quarter, that they are going to warn,” Tim Ghriskey, chief investment officer at Solaris Asset Management, told Reuters.

• Micron Technology Inc. (MU) yesterday (Wednesday) posted its seventh consecutive quarterly loss with a net loss of $344 million or 45 cents per share for the fiscal fourth quarter. “The global memory market continues to experience severe oversupply and price degradation,” said the memory-chip maker’s Chief Executive Steve Appleton, The Wall Street Journal reported.

• A study released yesterday (Wednesday) by Consumer Reports found that cereals marketed to children in the U.S. often have more sugar and sodium than their foreign-sold counterparts. Post Golden Crisp from Kraft Foods Inc. (KFT) and Kellogg Co.’s (K) Honey Smacks are both 50% sugar by weight, Reuters reported.

• Auto sales in Canada increased 1.7% in September, Bloomberg News reported. Toyota Motor Corp. (TM) had a 14% increase, which helped offset declines from both General Motors Corp. (GM) and Ford Motor Co. (F). Car sales climbed 5.1% while light truck sales slipped 2.2%.

Subscribe by RSS Subscribe by Email